ARTICLE | Company News
Stakeholders mulling new pricing models
October 6, 2015 1:29 AM UTC
Representatives from HHS, Express Scripts Holding Co. (NASDAQ:ESRX) and Pfizer Inc. (NYSE:PFE) suggested that innovative, value-based pricing models could help to address concerns about the high cost of specialty drugs.
The comments came Monday at a Pew Charitable Trusts forum to discuss policy options for managing the cost of PCSK9 inhibitors and other specialty drugs. ...